Ryan Martins

Director of Finance/CFO at 89BIO, INC.

49 year

Health Technology

Finance

Consumer Services

Profile

Ryan Stephen Martins is currently Chief Financial Officer at 89bio, Inc., a position held since 2019.
Formerly, Mr. Martins was Chief Financial Officer at Revolution Medicines, Inc. in 2018; VP-Corporate Strategy & Investor Relations at Ultragenyx Pharmaceutical, Inc. from 2015 to 2018; Senior Biotechnology Analyst at Jefferies LLC from 2014 to 2015; Senior Biotechnology Analyst at FM Partners Holdings LLC from 2013 to 2014; Vice President at Barclays Capital, Inc. from 2008 to 2011; Associate at Lehman Brothers, Inc. from 2006 to 2008; Principal at Chiron Corp.
in 2006.
Education includes degrees from Virginia Polytechnic Institute & State University (graduate, 2001), the University of Mumbai (undergraduate and graduate), Haas School of Business (MBA), and St. Xavier's College (undergraduate).

Ryan Martins active positions

Companies	Position	Start
89BIO, INC.	Director of Finance/CFO	30/06/2019

All active positions of Ryan Martins

Former positions of Ryan Martins

Companies	Position	End
REVOLUTION MEDICINES, INC.	Director of Finance/CFO	30/09/2018
ULTRAGENYX PHARMACEUTICAL INC.	Investor Relations Contact	28/02/2018
Jefferies LLC Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	30/06/2015
FM Partners Holdings LLC FM Partners Holdings LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	30/01/2014
Barclays Capital, Inc. Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	-

See the detail of Ryan Martins's experience

Training of Ryan Martins

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ryan Martins's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
Chiron Corp. Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening	Health Technology
Lehman Brothers, Inc. Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services	Finance
Ultragenyx Pharmaceutical, Inc. Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases	Health Technology
Jefferies LLC Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Barclays Capital, Inc. Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services	Finance
FM Partners Holdings LLC FM Partners Holdings LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Virginia Polytechnic Institute & State University Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Mumbai University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Haas School of Business Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
St. Xavier's College St. Xavier's College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Revolution Medicines, Inc. Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products	Health Technology
89bio, Inc. 89bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology